BIOHAVEN LTD
BHVNNYSE🏆 #1803 by market capEarnings Nov 17US Equity
$15.52▲ $0.23 (+1.50%)
🌅 Pre-market$15.30▼ 1.42%Regular close · extended-hours price shownTrack BHVN
Get earnings, price moves & breaking news on Telegram
24h▲ 1.5%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$2.34B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
BIOHAVEN LTD
BHVNAnalyst Ratings
Price
$15.52
Total
25
Raised
0
Lowered
6
Avg PT
$24.67
H / L
$48 / $11
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
RBC Capital | Reiterated | Sector Perform | 2026-10-23 | $19.00 | +22.40% |
HC Wainwright & Co. | Reiterated | Neutral | 2026-09-10 | — | — |
Morgan Stanley | Reiterated | Overweight | 2026-08-12 | $19.00 | +22.40% |
B of A Securities | Downgraded | Neutral → Underperform | 2026-06-29 | — | — |
Citigroup | Reiterated | Buy | 2026-04-02 | — | — |
TD Cowen | Reiterated | Buy | 2026-03-11 | — | — |
UBS | Downgraded | Buy → Neutral | 2025-11-26 | $11.00 | −29.10% |
JP Morgan | Reiterated | Overweight | 2025-11-20 | $23.00 | +48.20% |
BTIG | Reiterated | Buy | 2025-11-18 | $59.00 | +280.20% |
Bernstein | Downgraded | Outperform → Market Perform | 2025-11-06 | $57.00 | +267.30% |
William Blair | Downgraded | Outperform → Market Perform | 2025-11-05 | — | — |
Leerink Partners | Reiterated | Outperform | 2025-08-12 | $15.00 | −3.40% |
Baird | Reiterated | Outperform | 2025-08-12 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2024-12-17 | — | — |
Piper Sandler | Reiterated | Overweight | 2023-11-15 | — | — |
SVB Leerink | Reiterated | Outperform | 2023-01-24 | — | — |
Wedbush | Downgraded | Outperform → Neutral | 2022-08-08 | — | — |
Mizuho | Reiterated | Buy | 2022-03-03 | — | — |
Goldman Sachs | Reiterated | Buy | 2021-10-06 | $23.00 | +48.20% |
Canaccord Genuity | Reiterated | Buy | 2021-08-03 | $21.00 | +35.30% |
Cowen & Co. | Reiterated | Outperform | 2020-04-17 | — | — |
Oppenheimer | Reiterated | Perform | 2020-03-31 | — | — |
PiperJaffray | Reiterated | Overweight | 2019-05-08 | — | — |
Leerink Swann | Reiterated | Outperform | 2018-11-13 | — | — |
Barclays | Downgraded | Overweight → Equal Weight | 2018-04-05 | — | — |
Institution
RBC Capital
Reiterated · Sector Perform · 2026-10-23
$19.00
+22.40%
HC Wainwright & Co.
Reiterated · Neutral · 2026-09-10
—
—
Morgan Stanley
Reiterated · Overweight · 2026-08-12
$19.00
+22.40%
B of A Securities
Downgraded · Neutral → Underperform · 2026-06-29
—
—
Citigroup
Reiterated · Buy · 2026-04-02
—
—
TD Cowen
Reiterated · Buy · 2026-03-11
—
—
UBS
Downgraded · Buy → Neutral · 2025-11-26
$11.00
−29.10%
JP Morgan
Reiterated · Overweight · 2025-11-20
$23.00
+48.20%
BTIG
Reiterated · Buy · 2025-11-18
$59.00
+280.20%
Bernstein
Downgraded · Outperform → Market Perform · 2025-11-06
$57.00
+267.30%
William Blair
Downgraded · Outperform → Market Perform · 2025-11-05
—
—
Leerink Partners
Reiterated · Outperform · 2025-08-12
$15.00
−3.40%
Baird
Reiterated · Outperform · 2025-08-12
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2024-12-17
—
—
Piper Sandler
Reiterated · Overweight · 2023-11-15
—
—
SVB Leerink
Reiterated · Outperform · 2023-01-24
—
—
Wedbush
Downgraded · Outperform → Neutral · 2022-08-08
—
—
Mizuho
Reiterated · Buy · 2022-03-03
—
—
Goldman Sachs
Reiterated · Buy · 2021-10-06
$23.00
+48.20%
Canaccord Genuity
Reiterated · Buy · 2021-08-03
$21.00
+35.30%
Cowen & Co.
Reiterated · Outperform · 2020-04-17
—
—
Oppenheimer
Reiterated · Perform · 2020-03-31
—
—
PiperJaffray
Reiterated · Overweight · 2019-05-08
—
—
Leerink Swann
Reiterated · Outperform · 2018-11-13
—
—
Barclays
Downgraded · Overweight → Equal Weight · 2018-04-05
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space